BioMarin Pharmaceutical
BMRN
#1452
Rank
A$18.57 B
Marketcap
$97.44
Share price
1.42%
Change (1 day)
-27.42%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): A$0.58 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$2.75 Billion. In 2023 the company made an earning of A$0.28 Billion, an increase over its 2022 earnings that were of A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.58 B101.01%
2023 A$0.28 B26.07%
2022 A$0.22 B-298.51%
2021 -A$0.12 Billion78.04%
2020 -A$65 Million-55.36%
2019 -A$0.15 Billion-33.56%
2018 -A$0.22 Billion297.78%
2017 -A$55.1 Million-95.68%
2016 -A$1.28 Billion437.12%
2015 -A$0.24 Billion23.91%
2014 -A$0.2 Billion-29.25%
2013 -A$0.28 Billion49.23%
2012 -A$0.19 Billion171.11%
2011 -A$67 Million103.01%
2010 -A$33.01 Million-3903.54%
2009 A$0.86 M-98.31%
2008 A$51.32 M-189.7%
2007 -A$57.23 Million51.02%
2006 -A$37.9 Million-61.58%
2005 -A$98.62 Million-56.59%
2004 -A$0.23 Billion95.13%
2003 -A$0.12 Billion12.09%
2002 -A$0.11 Billion73.19%
2001 -A$59.97 Million18.32%
2000 -A$50.68 Million19.65%
1999 -A$42.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.8 Billion-232.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.32 Billion-152.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$62.5 Million-110.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.37 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-A$0.16 Billion-125.51%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.14 B-76.10%๐Ÿ‡บ๐Ÿ‡ธ USA